Premium
The Role of Big Data and Advanced Analytics in Drug Discovery, Development, and Commercialization
Author(s) -
Szlezák N,
Evers M,
Wang J,
Pérez L
Publication year - 2014
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2014.29
Subject(s) - commercialization , big data , drug discovery , data science , biopharmaceutical , drug development , health care , analytics , clinical pharmacology , engineering ethics , medicine , computer science , pharmacology , business , drug , political science , engineering , bioinformatics , marketing , microbiology and biotechnology , data mining , biology , law
In recent years, few ideas have captured the imagination of health‐care practitioners as much as the advent of “big data” and the advanced analytical methods and technologies used to interpret it—it is a trend seen as having the potential to revolutionize biology, medicine, and health care. 1 , 2 , 3 As new types of data and tools become available, a unique opportunity is emerging for smarter and more effective discovery, development, and commercialization of innovative biopharmaceutical drugs. Clinical Pharmacology & Therapeutics (2014); 95 5, 492–495. doi: 10.1038/clpt.2014.29